<DOC>
	<DOCNO>NCT01991509</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability blood level LBR-101 administer intravenously subcutaneously healthy volunteer .</brief_summary>
	<brief_title>Safety Bioavailability IV SC LBR-101</brief_title>
	<detailed_description />
	<criteria>Generally Healthy , Signed Approved Informed Consent , BMI 17.534.5 kg/m2 , Willing able comply CRU rule regulation study schedule Clinically significant medical psychiatric condition , Febrile illness within 5 day dose , Pregnant Nursing Females . History alcoholism , drug addiction positive drug/alcohol screen , History hypersensitivity inject protein monoclonal antibody , Unwilling unable comply protocol specify lifestyle guideline , Investigational site staff member , Use 3 prescription nonprescription medication daily , Acetaminophen use dose high 1 g more/day , Daily Aspirin use high 325 mg/day , Treatment investigational drug within 30 day dose , Use biologics within 6 month screen , Any clinically significant abnormality 12Lead ECG , Positive result HIV , Hepatitis B , Hepatitis C , Any clinically significant abnormality Blood Chemistry Hematology Urinalysis , Positive Pregnancy Test .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>